A fivefold higher expression of ObR was seen in primary ovarian cancer CaOV-3 and a ninefold higher in serous carcinoma OVCAR-3 cells derived from a tumour resistant to chemotherapy. Here, LEPR is linked to serous adenocarcinoma.